NEKTAR THERAPEUTICS — Director's Dealing 2013

Feb 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2013-02-01

Reporting Person: GREER R SCOTT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-01	Common Stock	M	7500	—	Acquired	50833	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-01	Restricted Stock Unit	$	M	7500	Disposed		Common Stock (7500)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock

F2: This restricted stock unit was granted on February 1, 2010 and vested in monthly installments over the three-year period following the grant date.